NDC 0006-3066 – Emend
Aprepitant 125 mg/1 · Powder, For Suspension · Oral
Product NDC0006-3066
Product details
- Brand name
- Emend
- Generic name
- Aprepitant
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Powder, For Suspension
- Route
- Oral
- Marketing category
- NDA · NDA207865
- Marketed since
- December 17, 2015
- Listing expires
- December 31, 2026
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Aprepitant 125 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0006-3066-03 | 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01) | Dec 17, 2015 |
Recalls mentioning this NDC
- D-0241-2026 Dec 31, 2025 · Class II
Presence of particulate matter: potential presence of metal particulates in the product.
Other Emend products
- 0006-0461 Aprepitant 80 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0006-0462 Aprepitant 125 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0006-0464 Aprepitant 40 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0006-3061 Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Merck Sharp & Dohme LLC
- 0006-3862 · Kit · Merck Sharp & Dohme LLC